Discover the complete list of Active Pharmaceutical Ingredients (APIs) manufactured or distributed by Synthélabo Pharmacie. View detailed product information, certifications, and sourcing options for each API. Connect with Synthélabo Pharmacie for compliant, high-quality pharmaceutical ingredients trusted by global clients.
Country: France
Supplier Description: Synthélabo Pharmacie was a major French pharmaceutical company formed in 1970 from the merger of two historic French laboratories: Laboratoires Dausse (founded in 1834) and Laboratoires Robert & Carrière (founded in 1899). In 1973, the cosmetics giant L'Oréal acquired a majority stake in Synthélabo, marking its entry into the pharmaceutical sector. Synthélabo expanded through acquisitions in the 1990s, notably Laboratories Delalande and Laboratoires Delagrange, and developed a strong presence in various therapeutic areas, including cardiovascular and central nervous system treatments. In 1999, Synthélabo merged with Sanofi, another major French pharmaceutical company, to form Sanofi-Synthélabo. This merger created one of Europe’s leading pharmaceutical groups, combining extensive product portfolios, R&D capabilities, and international reach. After the merger, the company focused exclusively on pharmaceuticals, divesting other business lines such as cosmetics and animal health. Today, the legacy of Synthélabo continues as part of Sanofi, one of the world’s largest pharmaceutical companies. - Show More
